Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Sunday, November 02, 2014 10:41:45 AM
bullish
cci(50) crosses 100 upwards
http://stockcharts.com/school/doku.php?st=cci&id=chart_school:technical_indicators:commodity_channel_index_cci
$VRTX recent news/filings
## source: finance.yahoo.com
Thu, 30 Oct 2014 20:18:14 GMT ~ Vertex to Present at the Credit Suisse Healthcare Conference on November 11
[at noodls] - October 30, 2014 BOSTON--(BUSINESS WIRE)-- http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.vrtx.com&esheet=50973628&newsitemid=20141030006484&lan=en-US&anchor=Vertex%2BPharmaceuticals%2BIncorporated&index=1&md5=06cec6662fd05e724afb1332f240c94aVertex ...
read full: http://www.noodls.com/view/9D2A66ED62970CBAAA8D836553CB811FA25CD472
*********************************************************
Thu, 30 Oct 2014 20:01:00 GMT ~ Vertex to Present at the Credit Suisse Healthcare Conference on November 11
[Business Wire] - Vertex Pharmaceuticals Incorporated today announced that it will present at the Credit Suisse Healthcare Conference on Tuesday, November 11 at 12:00 p.m. ET.
read full: http://finance.yahoo.com/news/vertex-present-credit-suisse-healthcare-200100309.html
*********************************************************
Thu, 30 Oct 2014 16:18:56 GMT ~ Boston’s Longest-Serving Mayor, Menino, Dies at 71; Had 'No Other Ambition'
read full: http://finance.yahoo.com/news/thomas-m-menino-boston-longest-161856656.html
*********************************************************
Wed, 29 Oct 2014 17:50:39 GMT ~ Twitter gives out 47% of its revenue in stock bonuses
read full: http://www.marketwatch.com/News/Story/Story.aspx?guid=D384219C-5EE6-11E4-9C44-3FB1D5A5D6E3&siteid=yhoof2
*********************************************************
Wed, 29 Oct 2014 16:00:01 GMT ~ Vertex Pharmaceuticals Posts Narrower-than-Expected Loss
read full: http://finance.yahoo.com/news/vertex-pharmaceuticals-posts-narrower-expected-160001154.html
*********************************************************
$VRTX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$VRTX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/VRTX/company-info
Ticker: $VRTX
OTC Market Place: Not Available
CIK code: 0000875320
Company name: Vertex Pharmaceuticals Inc.
Company website: http://www.vpharm.com
Incorporated In: MA, USA
$VRTX share structure
## source: otcmarkets.com
Market Value: $26,817,503,877 a/o Oct 31, 2014
Shares Outstanding: 238,081,533 a/o Jul 25, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$VRTX extra dd links
Company name: Vertex Pharmaceuticals Inc.
Company website: http://www.vpharm.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=VRTX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=VRTX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=VRTX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/news - http://finance.yahoo.com/q/h?s=VRTX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/VRTX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=VRTX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/VRTX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Vertex+Pharmaceuticals+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Vertex+Pharmaceuticals+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Vertex+Pharmaceuticals+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.vpharm.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.vpharm.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.vpharm.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/VRTX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000875320&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=VRTX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=VRTX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=VRTX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=VRTX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=VRTX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=VRTX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=VRTX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/VRTX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=VRTX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/VRTX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=VRTX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/VRTX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/VRTX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/VRTX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=VRTX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=VRTX
$VRTX DD Notes ~ http://www.ddnotesmaker.com/VRTX
Recent VRTX News
- Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain • Business Wire • 04/18/2024 12:00:00 PM
- Costco Increases Dividend by 14%, Meta Introduces ‘Artemis’ AI Chip, and More News • IH Market News • 04/11/2024 11:24:54 AM
- Vertex Enters Into Agreement to Acquire Alpine Immune Sciences • Business Wire • 04/10/2024 08:01:00 PM
- Vertex Enters Into Agreement to Acquire Alpine Immune Sciences • Business Wire • 04/10/2024 08:01:00 PM
- Vertex to Announce First Quarter 2024 Financial Results on May 6 • Business Wire • 04/09/2024 08:05:00 PM
- Vertex annonce que la présentation de drogue nouvelle d'Exagamglogène Autotemcel (exa-cel) a été acceptée pour évaluation prioritaire par Santé Canada pour le traitement de l'anémie falciforme et de la bêta-thalassémie dépendante des transfusion • PR Newswire (Canada) • 04/01/2024 03:00:00 PM
- Vertex Announces New Drug Submission for Exagamglogene Autotemcel (exa-cel) Has Been Accepted for Priority Review by Health Canada for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia • PR Newswire (Canada) • 04/01/2024 03:00:00 PM
- Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease • Business Wire • 04/01/2024 12:00:00 PM
- Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) • Business Wire • 03/21/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 10:08:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 10:02:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:59:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:55:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:50:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:44:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:37:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:29:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:24:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 06:19:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 04:25:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 04:10:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 03:52:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 03:44:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 03:26:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:28:11 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM